1. Home
  2. NRK vs SPRY Comparison

NRK vs SPRY Comparison

Compare NRK & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen New York AMT-Free Quality Municipal Income Fund

NRK

Nuveen New York AMT-Free Quality Municipal Income Fund

N/A

Current Price

$10.44

Market Cap

888.1M

Sector

Finance

ML Signal

N/A

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

N/A

Current Price

$8.38

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NRK
SPRY
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
888.1M
1.0B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
NRK
SPRY
Price
$10.44
$8.38
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
458.0K
900.5K
Earning Date
01-01-0001
06-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$84,278,000.00
Revenue This Year
N/A
$109.11
Revenue Next Year
N/A
$91.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.30
$6.66
52 Week High
$10.60
$18.63

Technical Indicators

Market Signals
Indicator
NRK
SPRY
Relative Strength Index (RSI) 58.27 32.64
Support Level $9.97 $8.05
Resistance Level $10.50 $10.44
Average True Range (ATR) 0.06 0.46
MACD -0.01 -0.01
Stochastic Oscillator 33.33 3.78

Price Performance

Historical Comparison
NRK
SPRY

About NRK Nuveen New York AMT-Free Quality Municipal Income Fund

Nuveen New York AMT-Free Quality Municipal Income Fund is a closed-end investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: